National Estimates of Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Hospitalized Patients in the United States

04 March 2021

Treating patients with infections due to multidrug-resistant pathogens often requires substantial healthcare resources. The purpose of this study was to report estimates of the healthcare costs associated with infections due to multidrug-resistant bacteria in the United States (US).

We found that antimicrobial-resistant infections led to substantial healthcare costs.

Further reading: Clinical Infectious Diseases

Author(s): Richard E Nelson, Kelly M Hatfield, Hannah Wolford, Matthew H Samore, R Douglas Scott, II, Sujan C Reddy, Babatunde Olubajo, Prabasaj Paul, John A Jernigan, James Baggs

Effective Surveillance